Amec Foster Wheeler wins world-scale methionine facility contract

Amec Foster Wheeler’s role has begun with basic engineering and cost estimate support activities and will evolve into the EPCM phase before the end of 2016. The expected plant start-up and commercial operation is set for 2019.

With an annual production capacity of 150,000 metric tons, the facility will produce the amino acid DL-methionine for animal nutrition which Evonik markets under the MetAMINO^® brand name. The construction of the plant complex is planned next to the existing Evonik methionine plant on Jurong Island in Singapore. Its location allows Evonik to serve especially well the Asian growth markets.

Roberto Penno, Amec Foster Wheeler Group President for Asia, Middle East, Africa and Southern Europe, said:

“This award is testament to our proven strategy and track record in delivering complex greenfield projects. We will deploy the significant technical and construction expertise of our in-country team to deliver this prestige facility and look forward to further developing our important partnership with Evonik."